Current Prospective of Anti-IL-4, -IL-9, and -IL-13 Therapies in Allergic Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-2710|4|3|222-230

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.4, Iss.3, 2010-11, pp. : 222-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Interleukin (IL) 5 for Asthma and Hypereosinophilic Diseases

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 201-209

Bentham Science Publishers

Access to resources Recommend Favorite

The IL-17 Family of Cytokines - Applications in Respiratory Medicine and Allergology

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 2, 2008-06 ,pp. : 82-91

Bentham Science Publishers

Access to resources Recommend Favorite

Patenting on Non Oral Anti-Allergic Drug

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 3, 2008-11 ,pp. : 222-225

Bentham Science Publishers

Access to resources Recommend Favorite

New Developments and Prospective Applications for #946; (1,3) Glucans

By  

Recent Patents on Biotechnology, Vol. 1, Iss. 1, 2007-02 ,pp. : 59-73

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Bacterial DNA in Inflammatory and Allergic Disease

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 2, 2008-01 ,pp. : 117-122

Bentham Science Publishers

Access to resources Recommend Favorite